Peer Review reports
From: Potential antiviral peptides targeting the SARS-CoV-2 spike protein
| Original Submission | ||
|---|---|---|
| 17 May 2022 | Submitted | Original manuscript |
| 24 Sep 2022 | Reviewed | Reviewer Report |
| 1 Oct 2022 | Reviewed | Reviewer Report |
| 24 Oct 2022 | Author responded | Author comments - Aaya Nassar |
| Resubmission - Version 2 | ||
| 24 Oct 2022 | Submitted | Manuscript version 2 |
| 27 Oct 2022 | Author responded | Author comments - Aaya Nassar |
| Resubmission - Version 3 | ||
| 27 Oct 2022 | Submitted | Manuscript version 3 |
| 10 Nov 2022 | Reviewed | Reviewer Report |
| 11 Nov 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 15 Nov 2022 | Editorially accepted | |
| 2 Dec 2022 | Article published | 10.1186/s40360-022-00627-w |
You can find further information about peer review here.